Stability and sensitivity insights into two-dose HPV vaccination effects and cervical cancer

Key Points

• Cervical cancer risk decreases significantly with two-dose HPV vaccination—up to 90% reduction observed.
• Key evidence shows improved immunogenicity within one year post-vaccination, supporting effectiveness.
• Assessment using stability and sensitivity analyses highlights potential variations in vaccine response across populations.
• These findings may enable better vaccination strategies, highlighting the need for widespread HPV vaccination.